Isconova AB reported consolidated and company earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, on consolidated basis, the company reported net sales of SEK 4,750,000 compared to SEK 8,159,000 a year ago. Operating loss was SEK 11,504,000 compared to SEK 6,259,000 a year ago. Loss before tax was SEK 11,383,000 compared to SEK 6,205,000 a year ago. Loss for the year was SEK 11,385,000 or SEK 1.64 per share before ad after dilution compared to SEK 6,368,000 or SEK 1.53 per share before ad after dilution a year ago. Cash used in operating activities was SEK 4,410,000 compared to SEK 4,455,000 a year ago. Investment in intangible fixed assets was SEK 112,000 compared to SEK 945,000 a year ago. For the full year, on consolidated basis, the company reported net sales of SEK 18,511,000 compared to SEK 22,967,000 a year ago. Operating loss was SEK 37,808,000 compared to SEK 33,995,000 a year ago. Loss before tax was SEK 37,681,000 compared to SEK 33,271,000 a year ago. Loss for the year was SEK 37, 885,000 or SEK 7.81 per share before ad after dilution compared to SEK 33,941,000 or SEK 8.29 per share before ad after dilution a year ago. Cash used in operating activities was SEK 32,866,000 compared to SEK 28,439,000 a year ago. Investment in intangible fixed assets was SEK 1,281,000 compared to SEK 1,405,000 a year ago. For the quarter, the company reported net sales of SEK 3,817,000 compared to SEK 6,852,000 a year ago. Loss before tax was SEK 9,610,000 compared to SEK 2,778,000 a year ago. Loss for the year was SEK 9,610,000 compared to SEK 2,942,000 a year ago. Cash used in operating activities was SEK 4,410,000 compared to SEK 4,455,000 a year ago. Investment in intangible fixed assets was SEK 112,000 compared to SEK 945,000 a year ago. For the full year, the company reported net sales of SEK 14,381,000 compared to SEK 17,744,000 a year ago. Loss before tax was SEK 37,762,000 compared to SEK 33,324,000 a year ago. Loss for the year was SEK 37,944,000 compared to SEK 33,980,000 a year ago. Cash used in operating activities was SEK 4,410,000 compared to SEK 4,455,000 a year ago. Investment in intangible fixed assets was SEK 112,000 compared to SEK 945,000 a year ago.

Isconova AB reported consolidated and standalone earnings results for the third quarter and nine months ended September 30, 2012. For the quarter, on a consolidated basis, the company reported net sales of SEK 3.4 million against SEK 4.6 million for the same period last year. The decline in sales compared with the year-earlier period was mainly due to lower royalty income for veterinary products, which was extraordinary high in the third quarter of 2011. Operating loss was SEK 7.1 million against SEK 9.2 million for the same period last year. Loss after financial items was SEK 7.1 million against SEK 8.9 million for the same period last year. Loss for the period was SEK 7.1 million or SEK 1.71 per share before and after dilution against SEK 8.9 million or SEK 2.14 per share before and after dilution for the same period last year. Cash flow for the third quarter amounted to a deficit of SEK 9.0 million against a deficit of SEK 10.9 million for the same period last year. The change was primarily attributable to improved operating earnings. Acquisition of intangible assets was SEK 274,000 against SEK 194,000 for the same period last year. Acquisition of tangible assets was SEK 110,000. For the nine months, on a consolidated basis, the company reported net sales of SEK 13.8 million against SEK 12.7 million for the same period last year. Operating loss was SEK 26.3 million against SEK 29.7 million for the same period last year. Loss after financial items was SEK 26.3 million against SEK 29.0 million for the same period last year. Loss for the period was SEK 26.3 million or SEK 6.31 per share before and after dilution against SEK 29.0 million or SEK 7.08 per share before and after dilution for the same period last year. Cash flow for the nine months amounted to a deficit of SEK 30.9 million against a deficit of SEK 24.3 million for the same period last year. The change was due to lower EU prepaid grants compared with the year-earlier period. Acquisition of intangible assets was SEK 1,168,000 against SEK 903,000 for the same period last year. Acquisition of tangible assets was SEK 574,000 against SEK 31,000 for the same period last year. For the quarter, on a standalone basis, the company reported net sales of SEK 2,443,000 against SEK 2,104,000 for the same period last year. Operating loss was SEK 6,946,000 against SEK 11,414,000 for the same period last year. Loss after financial items was SEK 6,931,000 against SEK 1,080,000 for the same period last year. Loss for the period was SEK 6,931,000 against SEK 11,080,000 for the same period last year. For the nine months, on a standalone basis, the company reported net sales of SEK 10,564,000 against SEK 8,810,000 for the same period last year. Operating loss was SEK 28,102,000 against SEK 33,127,000 for the same period last year. Loss after financial items was SEK 28,034,000 against SEK 32,415,000 for the same period last year. Loss for the period was SEK 28,034,000 against SEK 32,415,000 for the same period last year.

Isconova AB announced that they will report Q4, 2012 results at 12:00 PM, Central European Standard Time on Feb 26, 2013